The medication was a net positive for the sarcopenia question in the population most at risk for it
Studies show that this class of drugs can be used to treat heart failure, liver disease, anxiety and depression, neurodegenerative disorders, kidney disease, sleep apnea, and addiction disorders
GLP-1 receptor activation enhances insulin secretion in response to meals, suppresses glucagon release (which reduces hepatic glucose production), slows gastric emptying, and promotes satiety
Parece que la razn por la que la carnitina no pudo aumentar la concentracin de carnitina en el msculo en estos estudios se debe a dos motivos: Baja biodisponibilidad (solo se absorbe el 20% de una dosis de 2-6 g) y limitacin en el transporte de carnitina hacia el msculo
None of this means the medication is doing something wrong